GlycoActive™ HMOs,
suitable for all
We deliver bioactives for every stage of life- whether you’re building a product for newborns, athletes, aging population, or furry friends
A natural blueprint for lifelong health
Human milk oligosaccharides (HMOs) are unique sugars found in breast milk—not for nutrition, but for immune, brain, and gut development.
At Inbiose, we recreate nature’s most powerful GlycoActive™ HMOs with precision fermentation, making them available to support health from infancy to adulthood.
What are GlycoActive™ HMOs?
GlycoActive™ HMOs are nature-identical complex carbohydrates found in breast milk, evolved not just to nourish, but to shape health in more profound ways.
1
Microbiome
HMOs fuel beneficial bacteria while crowding out unwanted microbes. Certain HMOs are known to support keys strains of Bifidobacteria, Akkermansia and, other beneficial species.
2
Immune Support
HMOs guide the immune system with precision. By influencing immune signaling, they promote balance: enhancing defense without overreaction.
3
Gut Health
HMOs help reinforce the gut barrier, supporting digestive integrity and resilience, building a solid foundation for health across life stages.
4
Other benefits
HMOs support infant cognitive development, metabolic wellness, joint mobility in pets, infection resilience in livestock, and even stress tolerance in plants.
6 GlycoActive™ HMOs
.png)
Fucosylated HMO
Most abundant HMO in human milk
Most formulated and researched HMO, with widespread benefits
Sialylated HMO
Rises significantly during lactation
Unique benefits for women during pregnancy
Neutral HMO
Found in high concentration in human milk
Structurally foundational for many other HMOs
Fucosylated HMO
Rises significantly during lactation
Selective microbiota support
Sialylated HMO
Most abundant sialylated HMO in breast milk
Carries sialic acid, a key building block for the brain
Neutral HMO
Unique prebiotic profile
Well researched across age groups
Infants
Kids
Teenagers
Adults
Mom to be
Sports
Pets
Mothers deliver different HMOs
While pregnant, women already start producing HMOs as early as the first trimester. There is great variability in quantity of individual HMOs that is produced in different women, and throughout the lactation period. One of the major differences is determined by genetics in the FUT2 gene: secretor vs non-secretor of 2'-FL.
.jpg)
Secretors
Graph adapted from
Liu et al., 2023
Non-secretors
Graph adapted from
Liu et al., 2023
Variation over 24 months of lactation
Graph representing a non-secretor group (12%) from a US cohort, adapted from Plows et al., 2021
.png)
